Baldness cure could be on shelves in two years They are already
talking with pharmaceutical firms about making the product,
which would work by stopping the effects of a single guilty
enzyme. US-based dermatologists announced earlier this year that
they had found that an enzyme, called prostaglandin D2 (PGD2),
instructed follicles to stop producing hair. They identified it
by screening 250 genes implicated in hair loss. George
Cotsarelis, head of dermatology at Pennsylvania University, said
the one responsible for levels of PGD2 played “the major role”.
He said he was now talking with several drugs firms about
creating the anti-baldness product. Read More... comments
powered by Disqus